<DOC>
	<DOCNO>NCT00855712</DOCNO>
	<brief_summary>The purpose study compare survival patient newly transplant heart follow heart transplantation among patient transplant donated heart preserve ice transplant donate heart use Organ Care System ( OCS ) . The Organ care system preserve heart warm blood perfuse beat state . The study also compare number rejection episode , heart related adverse event , ICU time , ventilation time two group . The study consider success survival OCS group inferior ice group .</brief_summary>
	<brief_title>Randomized Study Organ Care System Cardiac Preservation Donated Hearts Eventual Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Cardioplegic Solutions</mesh_term>
	<criteria>Recipient Day Transplant Registered male female primary heart transplant candidate â‰¥18 year old Signed , write informed consent document authorization use disclose protected health information Donor Hearts &lt; 60 year old Mean systolic blood pressure &gt; 60 mmHg time final heart assessment Satisfactory echocardiography assessment define : Ejection fraction &gt; 40 % Absence severe segmental wall motion abnormality Absence leave ventricular hypertrophy ( inter ventricular septum posterior wall thickness &lt; 1.3 cm ) Absence valve abnormality ( trace mild valvular regurgitation acceptable ) Recipient Day Transplant &gt; 4 previous sternotomies Chronic renal failure define chronic serum creatinine &gt; 3.0 mg/dL 2 week and/or require hemodialysis ( except hemodialysis hemofiltration fluid overload ) Ventilator dependence time transplant Use ventricular assist device &gt; 30 day presence following : sepsis , intracranial hemorrhage heparin induce thrombocytopenia Panel reactive antibody &gt; 40 % positive prospective cross match and/or virtual cross match Use investigational drug device , OCS , study . Simultaneous transplant nonheart allograft , except concurrent kidney transplant Donor Hearts Abnormal coronary angiogram define &gt; 50 % stenosis , require coronary bypass Donortorecipient body weight ratio &lt; 0.6 Inotrope support time final heart assessment include , limited : Dopamine &gt; 10 ug/kg/min Dobutamine &gt; 10 ug/kg/min Milrinone &gt; 0.3 ug/kg/min Epinephrine &gt; 0.03 ug/kg/min Norepinephrine &gt; 0.03 ug/kg/min Any bolus dose prior explants would result exceed state criterion Presence exclusion criterion base standard practice investigational site</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Transplant</keyword>
	<keyword>Warm Perfusion</keyword>
	<keyword>Organ Care</keyword>
	<keyword>Resting Mode</keyword>
</DOC>